The aim of this study was to explore the prevalence of systemic lupus erythematosus (SLE) in Lithuania (Vilnius). Two different studies were designed for SLE cases identification: registry-based SLE study and population-based SLE study. For the registry-based study patients were enrolled during the period of 1999-2004 and from two sources, including out-patient clinics of Vilnius and tertiary rheumatology center with interview during the year 2004. Only Vilnius residents who fulfilled the ACR 1982 revised criteria for the classification of SLE were counted in this study. Seventy-six living adult patients with SLE were interviewed and accounted for the prevalence of 16.2/100000 (0.016%) using the Vilnius adult population in January 2004 (a population of 470451). The population study of randomly selected 10,000 Vilnius inhabitants with beforehand validation of the survey was performed in the same year. The population-based study revealed two cases for 4017 respondents, but the low response rate may be important. Extrapolating the results to population of 10000 inhabitants, the point prevalence of SLE in the entire sample was at least 0.02%. Therefore, the prevalence of SLE in Lithuania is the lowest if compared to Northern European countries.
We thank Dr Nurullah Akkoc for his interest in our work and his careful reading of the manuscript, which highlights a misprint in the Results section concerning the age-standardized spondyloarthropathy (SpA) prevalence in women (1). The true standardized rate for women for SpA is 0.40% [95% confidence interval (CI) 0.21-0.66]. It should be emphasized that the raw data for men and women and the standardized rheumatoid arthritis (RA) and SpA prevalence data are exact in the article and should be considered as presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.